(Q28378679)

1

0 references

R Costa-Perira

2

0 references

K Nagrajan

3

0 references

N Vishvanathan

4

0 references

A D Bhatt

5

0 references

W Rittel

Antimicrobial Agents and Chemotherapy

6

0 references

language of work or name

English

0 references

publication date

February 1993

0 references

published in

0 references

volume

37

0 references

issue

2

0 references

page(s)

183-6

0 references

cites work

Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Impact of pH and cationic supplementation on in vitro postantibiotic effect

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Anti-anaerobic antibacterial agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Drug resistance trends in Mycobacterium tuberculosis: Blackburn 1985-89.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

The global tuberculosis situation and the new control strategy of the World Health Organization

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187635

Rifampicin1, 2, Isoniazid, Ethambutol, Ethionamide, and Streptomycin in Murine Tuberculosis : Comparative Chemotherapeutic Studies

20 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8452346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8452346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Conditions affecting the results of susceptibility testing for the quinolone compounds

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8452346